{"id":"https://openalex.org/W4390191901","doi":"https://doi.org/10.1002/alz.082916","title":"Prevalence of Cerebral Microhemorrhages and Cortical Superficial Siderosis in APOE4/4 Homozygotes with Early Alzheimer\u2019s disease: Baseline Findings from Phase 3 Trial of Oral ALZ\u2010801 in APOE4/4 Homozygotes (APOLLOE4)","display_name":"Prevalence of Cerebral Microhemorrhages and Cortical Superficial Siderosis in APOE4/4 Homozygotes with Early Alzheimer\u2019s disease: Baseline Findings from Phase 3 Trial of Oral ALZ\u2010801 in APOE4/4 Homozygotes (APOLLOE4)","publication_year":2023,"publication_date":"2023-12-01","ids":{"openalex":"https://openalex.org/W4390191901","doi":"https://doi.org/10.1002/alz.082916"},"language":"en","primary_location":{"id":"doi:10.1002/alz.082916","doi":"https://doi.org/10.1002/alz.082916","is_oa":true,"landing_page_url":"https://doi.org/10.1002/alz.082916","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.082916","source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.082916","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113687686","display_name":"Susan R. Abushakra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Susan Abushakra","raw_affiliation_strings":["Alzheon, Inc., Framingham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheon, Inc., Framingham, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093577843","display_name":"Rosalind McLaine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosalind McLaine","raw_affiliation_strings":["Alzheon Inc., Framingham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheon Inc., Framingham, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080281958","display_name":"Jerome A. Barakos","orcid":"https://orcid.org/0000-0001-9117-2788","observed_orcids":["https://orcid.org/0000-0001-9117-2788"]},"institutions":[{"id":"https://openalex.org/I2801780550","display_name":"California Pacific Medical Center","ror":"https://ror.org/02bjh0167","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114073160","https://openalex.org/I2801780550"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jerome Barakos","raw_affiliation_strings":["California Pacific Medical Center, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"California Pacific Medical Center, San Francisco, CA, USA","institution_ids":["https://openalex.org/I2801780550"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033585095","display_name":"Anton P. Porsteinsson","orcid":"https://orcid.org/0000-0002-0166-1738","observed_orcids":["https://orcid.org/0000-0002-0166-1738"]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]},{"id":"https://openalex.org/I5388228","display_name":"University of Rochester","ror":"https://ror.org/022kthw22","country_code":"US","type":"education","lineage":["https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anton P. Porsteinsson","raw_affiliation_strings":["University of Rochester School of Medicine and Dentistry, Rochester, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Rochester School of Medicine and Dentistry, Rochester, NY, USA","institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069225906","display_name":"David Watson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Watson","raw_affiliation_strings":["Alzheimer\u2019s Research And Treatment Center, Lake Worth, FL  USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheimer\u2019s Research And Treatment Center, Lake Worth, FL  USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022046076","display_name":"Emer MacSweeney","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emer MacSweeney","raw_affiliation_strings":["Re-Cognition Health, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Re-Cognition Health, London, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111861964","display_name":"Earvin Liang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Earvin Liang","raw_affiliation_strings":["Alzheon Inc., Framingham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheon Inc., Framingham, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109311169","display_name":"Patrick J. Kesslak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick Kesslak","raw_affiliation_strings":["Alzheon Inc., Framingham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheon Inc., Framingham, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051106845","display_name":"Joyce Suhy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joyce Suhy","raw_affiliation_strings":["Clario, Inc., San Mateo, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clario, Inc., San Mateo, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110571932","display_name":"Aidan Power","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aidan Power","raw_affiliation_strings":["Alzheon, Inc., Framingham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheon, Inc., Framingham, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005005325","display_name":"John A. Hey","orcid":"https://orcid.org/0000-0002-5104-6231","observed_orcids":["https://orcid.org/0000-0002-5104-6231"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John A. Hey","raw_affiliation_strings":["Alzheon, Inc., Framingham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheon, Inc., Framingham, MA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078511740","display_name":"Martin Tolar","orcid":"https://orcid.org/0000-0002-3910-091X","observed_orcids":["https://orcid.org/0000-0002-3910-091X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Tolar","raw_affiliation_strings":["Alzheon, Inc., Framingham, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheon, Inc., Framingham, MA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5113687686"],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"19","issue":"S24","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11763","display_name":"Intracerebral and Subarachnoid Hemorrhage Research","score":0.5278000235557556,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11763","display_name":"Intracerebral and Subarachnoid Hemorrhage Research","score":0.5278000235557556,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.45019999146461487,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.015699999406933784,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cerebral-microhemorrhages","display_name":"cerebral microhemorrhages","score":0.9269999861717224},{"id":"https://openalex.org/keywords/superficial-siderosis","display_name":"superficial siderosis","score":0.8740000128746033}],"concepts":[{"id":"https://openalex.org/C2777790613","wikidata":"https://www.wikidata.org/wiki/Q191562","display_name":"Cerebral amyloid angiopathy","level":4,"score":0.9221687316894531},{"id":"https://openalex.org/C2780860705","wikidata":"https://www.wikidata.org/wiki/Q7643329","display_name":"Superficial siderosis","level":5,"score":0.9010251760482788},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7365634441375732},{"id":"https://openalex.org/C2780883591","wikidata":"https://www.wikidata.org/wiki/Q1413860","display_name":"Siderosis","level":2,"score":0.728329598903656},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.4389115571975708},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4182051420211792},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39136072993278503},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2622181177139282},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.17053928971290588}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/alz.082916","doi":"https://doi.org/10.1002/alz.082916","is_oa":true,"landing_page_url":"https://doi.org/10.1002/alz.082916","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.082916","source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1002/alz.082916","doi":"https://doi.org/10.1002/alz.082916","is_oa":true,"landing_page_url":"https://doi.org/10.1002/alz.082916","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.082916","source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4390191901.pdf","grobid_xml":"https://content.openalex.org/works/W4390191901.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4367305396","https://openalex.org/W4406223346","https://openalex.org/W4406224057","https://openalex.org/W4401587315","https://openalex.org/W7116882571","https://openalex.org/W2082346612","https://openalex.org/W7135064974","https://openalex.org/W7164160174","https://openalex.org/W4237180235","https://openalex.org/W4236405194"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Plaque":[2],"clearing":[3],"amyloid":[4,46,55,292,344],"antibodies":[5,293,345],"show":[6,254],"an":[7,73],"increased":[8,336],"risk":[9,22,35,52],"of":[10,26,40,53,79,152,175,219,239,257,274,283],"amyloid\u2010related":[11],"imaging":[12],"abnormalities":[13],"with":[14,24,29,60,89,105,144,195,213,260,289,303],"edema":[15],"or":[16,19,68],"hemorrhages":[17],"(ARIA\u2010E":[18],"ARIA\u2010H).":[20],"ARIA":[21,284,313,337],"increases":[23],"number":[25],"APOE4":[27,87,103,113,322],"alleles,":[28],"APOE4/4":[30,121,252,286,300,348],"homozygotes":[31,143,253],"showing":[32],"the":[33,51,173,280,290,330],"highest":[34],"related":[36],"to":[37],"high":[38,255,272,281],"burden":[39,273],"A\u03b2":[41,81],"plaque":[42],"in":[43,86,102,209,285,299,305,321,329],"microvessels":[44],"(cerebral":[45],"angiopathy,":[47],"CAA).":[48],"To":[49],"decrease":[50],"ARIA,":[54],"antibody":[56],"trials":[57,98,309],"exclude":[58],"subjects":[59,228,243],"CAA\u2010related":[61,317],"lesions":[62,131,178,259,276],"such":[63],"as":[64],">4":[65],"microhemorrhages":[66,153,266],"(MH)":[67],"superficial":[69,224],"siderosis.":[70],"ALZ\u2010801":[71,97,328],"(valiltramiprosate),":[72],"oral":[74],"drug":[75],"that":[76,204],"inhibits":[77],"formation":[78],"neurotoxic":[80],"oligomers,":[82],"shows":[83],"promising":[84],"efficacy":[85],"carriers":[88,104,323],"no":[90],"observed":[91],"ARIA\u2010E":[92,295],"(Abushakra":[93],"2017,":[94],"2022).":[95],"Two":[96],"are":[99],"currently":[100],"ongoing":[101,331],"Early":[106,145],"AD.":[107],"A":[108,217],"Phase":[109,117,137],"2":[110,227],"study":[111],"enrolled":[112,120],"carriers,":[114],"and":[115,156,172,226,232,262,267,339],"a":[116],"3":[118,138],"trial":[119,139],"patients.":[122,350],"Both":[123],"studies":[124,332],"allow":[125],">10":[126],"MH":[127,208],"and/or":[128],"some":[129],"siderosis":[130,158,269],"at":[132],"baseline.":[133],"Method":[134],"The":[135],"fully\u2010enrolled":[136],"(APOLLOE4)":[140],"included":[141],"325":[142,198],"AD":[146],"(MMSE":[147],"\u226522).":[148],"We":[149],"evaluated":[150,169],"prevalence":[151,256],"(MH),":[154],"macrohemorrhages":[155],"superificial":[157,268],"(CAA":[159],"lesions).":[160],"Baseline":[161],"MRIs":[162,203],"acquired":[163],"from":[164],"1.5T/3T":[165],"scanners":[166],"were":[167,235],"centrally":[168],"by":[170],"Clario,":[171],"number/location":[174],"these":[176],"CAA":[177,240,258,275],"is":[179,296],"reported.":[180],"Result":[181],"Subjects":[182],"had":[183,201,221,229,244],"mean":[184],"age":[185],"69":[186],"years,":[187],"51%":[188],"female,":[189],"MMSE":[190],"26,":[191],"82%":[192],"white,":[193],"65%":[194],"MCI.":[196],"Of":[197],"subjects,":[199],"313":[200],"baseline":[202],"showed":[205],">":[206,214],"1":[207,223],"32%,":[210],"including":[211],"9%":[212,220,263],"4":[215],"MH.":[216],"total":[218],"\u2265":[222],"siderosis,":[225],"macrohemorrahages.":[230],"Occipital":[231],"frontal":[233],"lobes":[234],"most":[236,277],"common":[237],"locations":[238],"lesions.":[241],"Most":[242],"white":[245],"matter":[246],"disease":[247],"(Fazekas":[248],"=":[249],"1).":[250],"Conclusion":[251],"32%":[261],"having":[264],"lobar":[265],"respectively.":[270],"This":[271,311],"likely":[278,314],"underlies":[279],"incidence":[282],"patients":[287,301],"treated":[288,302],"approved":[291],"(30%\u201060%).":[294],"also":[297],"reported":[298,320],"placebo":[304],"lecanemab":[306],"&":[307],"gantenerumab":[308],"(4%\u20106%).":[310],"background":[312],"reflects":[315],"spontaneous":[316],"inflammation":[318],"commonly":[319],"(CAA\u2010RI,":[324],"Regendhardt":[325],"2020).":[326],"Oral":[327],"has":[333,340],"not":[334],"shown":[335],"risk,":[338],"safety":[341],"advantage":[342],"over":[343],"especially":[346],"for":[347],"homozygous":[349]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-12-26T00:00:00"}